Also see: BP, Deere: Analysts' New RatingsEditor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES Analog Devices ( ADI) price target boosted at Citi to $52 from $49. Strong 2Q revs, solid print outlook, Citigroup said. Maintain Buy rating. Analog Devices ( ADI) price target boosted at Citi to $52 from $49. Strong 2Q revs, solid print outlook, Citigroup said. Maintain Buy rating. Aflac ( AFL) price target cut at Citi to $57 from $62. Good 1Q11 showing, but the risk of further losses in investments may temper near-term performance, Citigroup said. Maintain Hold rating. Aflac ( AFL) estimates, target cut at Morgan Stanley. AFL estimates were reduced through 2013, Morgan Stanley said. Management lowered its guidane. Overweight rating and new $64 price target. Abercrombie & Fitch ( ANF) numbers increased at Goldman through 2013, Goldman Sachs said. Company is realizing operating leverage. Buy rating and new $88 price target. Avago Technologies ( AVGO) added to Top Picks at Citi. AVGO added to Top Pick given 3Q smartphone strength and sharpening margin & valuation horizon, Citigroup said. Maintain Buy rating and $40 price target. BJ's Wholesale Club ( BJ) price target raised at Citi to $56 from $52 on 1Q11 beat and raise, Citigroup said. Maintain Hold rating. Chico's FAS ( CHS) target boosted at Morgan Stanley. Shares of CHS now seen reaching $14, according to Morgan Stanley. Company is keeping a tight lid on costs. Equal-weight rating. Deere ( DE) price target trimmed at Citi to $105 from $109. Solid 2Q results but pricing key to second half, Citigroup said. Maintain Buy rating. Deere ( DE) estimates, target reduced at Goldman. Shares of DE now seen reaching $104, according to Goldman Sachs. Estimates also cut, given higher production costs. Neutral rating. Eaton Vance ( EV) price target trimmed at Citi by a dollar to $29 on mixed outlook for volumes, Citigroup said. Maintain Sell rating. GenOn Energy ( GEN) price target lowered at Citi to $4.50 from $5.25. Earnings stemming from capacity revenues rather than energy margins may limit upside, Citigroup said. Maintain Buy rating. Hewlett-Packard ( HPQ) price target cut at Citi to $45 from $65 on weak results and disappointing 3Q guidance, Citigroup said. Maintain Buy rating.
JC Penney ( JCP) target raised at Morgan Stanley to $32. Company is cutting costs and buying back stock. Underweight rating. Limited Brands ( LTD) numbers increased at UBS. LTD estimates were raised through 2013, UBS said. Company is seeing higher margins. Buy rating and new $47 price target. Medtronic ( MDT) estimates reduced at BMO through 2013. Ardian purchase will cut into earnings. Outperform rating. PetSmart ( PETM) estimates, target raised at Goldman. Shares of PETM now seen reaching $50, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Buy rating. Reynolds American ( RAI) estimates upped at Goldman through 2013. Company is raising prices on smokeless tobacco. Sell rating. Staples ( SPLS) estimates, target lowered at Goldman. SPLS estimates were cut through 2013, Goldman Sachs said. Company is seeing slower sales and lower international margins. Neutral rating and new $19 price target. Stryker Corp ( SYK) price target lifted at Citi to $68 from $64. Annual investor meeting reinforced that the company can weather the challenging orthopedic market, Citigroup said. Maintain Hold rating. Stryker target boosted at UBS. Shares of SYK now seen reaching $72, according to UBS. Hip market can drive growth in the coming quarters. Buy rating. Target ( TGT) price target cut at Citi to $64 from $68. 1Q11 beats on credit leverage, but underlying business remains challenged by the macro environment. Maintain Buy rating. Target estimates lowered at BMO through 2012. Company is facing higher input costs. Outperform rating and $60 price target. End of report.